Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The unique study analyzed infants and their mothers.
New studies offer evidence that an unexpected virus plays a role—but it needs a helper.
Humans and companion animals get similar cancers, so clinical trials in dogs can lead to research in humans—and vice versa.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
As sexually transmitted infections surge nationwide, a California law—the first of its kind—requires health insurance to cover home tests.
A high-quality trial should improve access to dolutegravir for children worldwide.
The Food and Drug Administration approved the single-pill treatment for children weighing at least 30 pounds.
The proceeds will benefit St. Jude Children’s Research Hospital in Memphis.
New guidelines from the Department of Health and Human Services went into effect immediately.
An analysis of Danish families found that having a child with cancer didn’t affect family planning either.
The inquiry was the first of its kind to check the antibody status of patients and staff to uncover COVID-19 cases in this medical setting.
“This is excellent news for all children living with HIV.”
Sitting for long periods is associated with an increased risk of multiple diseases, including certain cancers, and a higher chance of death.
Germs aren’t all bad.
The prevalence of HIV among children admitted to one of South Africa’s largest hospitals dropped from 31.9 percent in 2005 to a still-high rat...
“How was school?” may be a hard question for kids with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.